Friday, June 21, 2024
|
|
|
|
12:30 - 13:00
| Sponsored by Astra Zeneca: IMFINZI in 1L ES-SCLC: Redefining the Survival Outcomes
| Dr. Arafat Tfayli
|
17:00 - 17:30
| Sponsored by BMS: Addressing the unmet needs in NSCLC treatment with immunotherapies
| Dr. Fadi Farhat
|
17:30 - 18:00
| Sponsored by MSD: Exploring the role of immunotherapy in the perioperative space in Early Stage Lung Cancer
| Dr. Hampig Kourie
|
18:00 - 18:30
| Sponsored by MSD: Evolving treatment paradigms: Surgery and Immuno-Oncology in early-stage Non-small cell lung cancer
| Dr. Jonathan Spicer
|
|
Saturday, June 22, 2024 |
12:00 - 12:30
| Sponsored by Janssen: New treatment paradigms in NSCLC EGFR mutated patient
| Dr. George El Hachem
|